The ChemQuest Group expanded its Technology Institute offerings to include Collaborative Innovation, led by VP Dr. Victoria Scarborough. 

 

Dr. Scarborough is an R&D leader and subject matter expert for the commercialization of in-demand new technology that leverages open innovation. 

 

The ChemQuest Technology Institute (CQTI) is a state-of-the-art R&D facility staffed by Ph.D. chemists that work in tandem with ChemQuest’s senior business strategy experts (former senior managers from multinational manufacturers and chemical business owners) to collaborate on IP de-risked coatings and adhesives solutions that deliver intrinsic value to end markets. 

 

CQTI’s services include formulation design, synthesis, and optimization that unlock the potential of existing or new molecules in a jointly developed molecular design, for example or target functional coatings properties for high-value end uses.

 

The ChemQuest Group focuses on specialty chemical value chains for the formulated products industry including paints, coatings, adhesives, sealants, elastomers, concretes, grouts, and mortar, plastics, inks, personal care products, HI&I sanitization products and other specialty chemical-derived products. 

 

By extension, CQTI is an entrée into formulation, testing, application processes as well as rapid vetting and commercialization. 

 

Clients are able to augment their internal resources with CQTI’s collaborative innovation expertise and access to conditions that mimic the performance of their product in the manufacturing setting. 

 

For the past 25+ years, Dr. Scarborough has advanced technology by creating and managing R&D and commercialization activities for the Sherwin-Williams Company in roles including director of New Technology (2007–2010), and program director of Global External Innovation (2010–2017). 

 

“There is a direct need for an external resource to vet all aspects of the innovation cycle without ego or career concerns,” Dr. Scarborough said. “This organization combines a deep understanding of market drivers with the vision for real, not incremental, innovation.”

 

“Dr. Scarborough’s multi-faceted background facilitating collaboration among technology owners, equity partners, and key stakeholders, will position ChemQuest clients for sustainable profitability in leading specialty chemicals’ markets,” ChemQuest CEO Dan Murad added.“Vickie has a remarkable track record for value creation that leverages open innovation to develop breakthrough products and processes amid stiff competition, global raw material shortages, and price pressures. ChemQuest is committed to supporting its clients by delivering distinctive, thorough, actionable, confidential and professional work. We look forward to launching a new decade of external technology development enabling excellence in research, accelerating our clients’ growth objectives, with significant contributions from Dr. Scarborough, ChemQuest’s team of experienced Ph.D. chemists and external partners, in our state-of-the-art R&D facility in South Boston, VA.”